+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Calcium channel antagonists, part I: Fundamental properties: Mechanisms, classification, sites of action



Calcium channel antagonists, part I: Fundamental properties: Mechanisms, classification, sites of action



Cardiovascular Drugs and Therapy 3(4): 477-477




(PDF emailed within 0-6 h: $19.90)

Accession: 062028655

Download citation: RISBibTeXText

DOI: 10.1007/bf01865502


Related references

Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action. Cardiovascular Drugs and Therapy 1(4): 411-430, 1987

Sites, mechanisms of action, and differentiation of calcium channel antagonists. American Journal of Hypertension 4(7 Pt 2): 422s-429s, 1991

Calcium antagonists: sites of action, pharmacological effect profile and clinical use. 1: Physiologic significance of calcium ions and mechanisms of action of calcium antagonists in the subcellular area. Zeitschrift für Arztliche Fortbildung 80(5): 191-197, 1986

Fundamental mechanisms of action of calcium antagonists in myocardial ischemia. American Journal of Cardiology 59(3): 75b-83b, 1987

Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials. Cardiovascular Drugs and Therapy 1(5): 461-491, 1988

Calcium channel antagonists part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials. Cardiovascular Drugs and Therapy 3(4): 478-478, 1989

Mechanisms of action of membrane calcium channel blockers and intracellular calcium antagonists. Medicinal Research Reviews 3(1): 21-42, 1983

Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use. Progress in Cardiovascular Diseases 38(4): 273-290, 1996

Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Cleveland Clinic Journal of Medicine 59(6): 617-627, 1992

Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacological Reviews 44(3): 363-376, 1992

Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites. Journal of Pharmacy and Pharmacology 37(6): 437-440, 1985

A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part III: Mechanisms of action of calcium antagonists. Journal of Clinical Neuroscience 1(3): 151-160, 1994

A view of the latest concepts of the voltage-dependent calcium channel and mechanisms of action of calcium channel modulators. Cardiovascular Drugs and Therapy 1(5): 439-440, 1988

Calcium antagonists: current and future applications based on new evidence. Classification of calcium channel blockers. Clinical Calcium 20(1): 24-30, 2010

Identification of binding sites for calcium channel antagonists. Japanese Heart Journal 37(5): 643-650, 1996